Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Ghosts of UNC's past and present
Every October, the whispers of UNC’s past seem to echo a little louder. For decades, students and staff have swapped legends of spirits that are...
Mon Nov 3, 2025

Residents flock to spooktacular Halloween celebration on Franklin Street
Hundreds of people flocked to Franklin Street on Friday to celebrate Halloween in Chapel Hill, North Carolina. The college town has been a popular spot...
Sat Nov 1, 2025

Interview with UNC Professor, Pulitzer Prize Winner Kathleen DuVal
Kathleen DuVal has a lot to say about early American history. Her latest book, Native Nations: A Millennium in North America, spans more than 700...
Fri Oct 31, 2025

'Halloweekend' in Chapel Hill, explained
Each year, the Town of Chapel Hill closes down Franklin Street for a massive impromptu parade. This tradition has been ongoing for decades and turnout...
Wed Oct 29, 2025